Literature DB >> 10989276

The importance of being K-Ras.

C A Ellis1, G Clark.   

Abstract

The ras genes give rise to a family of related proteins that have strong transforming potential. Typical in vitro studies fail to discriminate between the transforming activity of the Ras proteins. Although activating mutations in ras genes are commonly found in human disease, they are not evenly distributed between the different ras members. Instead, they are concentrated in k-ras. With the absence of evidence to suggest that k-ras DNA is more prone to mutation than h-ras DNA, this imbalance in mutational frequency suggests a special biological role for the K-Ras protein in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989276     DOI: 10.1016/s0898-6568(00)00084-x

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  40 in total

1.  Molecular Simulations of Solved Co-crystallized X-Ray Structures Identify Action Mechanisms of PDEδ Inhibitors.

Authors:  Ramin Ekhteiari Salmas; Mert Mestanoglu; Mine Yurtsever; Sergei Y Noskov; Serdar Durdagi
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

2.  Spontaneous transformation of a clonal population of dermis-derived multipotent cells in culture.

Authors:  Chunmeng Shi; Yue Mai; Ying Zhu; Tianmin Cheng; Yongping Su
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-18       Impact factor: 2.416

3.  Specific and Efficient Regression of Cancers Harboring KRAS Mutation by Targeted RNA Replacement.

Authors:  Sung Jin Kim; Ju Hyun Kim; Bitna Yang; Jin-Sook Jeong; Seong-Wook Lee
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

4.  Regulation of the Small GTPase Ras and Its Relevance to Human Disease.

Authors:  Kayla R Kulhanek; Jeroen P Roose; Ignacio Rubio
Journal:  Methods Mol Biol       Date:  2021

Review 5.  TGFbeta-regulated transcriptional mechanisms in cancer.

Authors:  Volker Ellenrieder; Anita Buck; Thomas M Gress
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.

Authors:  Thomas Kindler; Melanie G Cornejo; Claudia Scholl; Jianing Liu; Dena S Leeman; J Erika Haydu; Stefan Fröhling; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2008-07-28       Impact factor: 22.113

7.  Rare codons regulate KRas oncogenesis.

Authors:  Benjamin L Lampson; Nicole L K Pershing; Joseph A Prinz; Joshua R Lacsina; William F Marzluff; Christopher V Nicchitta; David M MacAlpine; Christopher M Counter
Journal:  Curr Biol       Date:  2012-12-13       Impact factor: 10.834

8.  Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.

Authors:  G Smith; R Bounds; H Wolf; R J C Steele; F A Carey; C R Wolf
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

9.  Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.

Authors:  Lisa D Mills; Yaqing Zhang; Ronald J Marler; Marta Herreros-Villanueva; Lizhi Zhang; Luciana L Almada; Fergus Couch; Cynthia Wetmore; Marina Pasca di Magliano; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

10.  Analysis of k-ras nuclear expression in fibroblasts and mesangial cells.

Authors:  Isabel Fuentes-Calvo; Ana M Blázquez-Medela; Eugenio Santos; José M López-Novoa; Carlos Martínez-Salgado
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.